{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["13(1)"],"submitter":["Gaggiano C"],"pubmed_abstract":["<h4>Introduction</h4>This study aims to explore awareness, knowledge, and diagnostic/therapeutic practices in monogenic uveitis (mU) among uveitis experts.<h4>Methods</h4>This is an explorative, cross-sectional survey study. An anonymous, semi-structured, electronic survey was delivered to uveitis experts from the Autoinflammatory Diseases Alliance (AIDA) Network and International Uveitis Study Group (IUSG). We included respondents answering ≥ 50% of the survey.<h4>Results</h4>Seventy-seven participants rated their knowledge of mU as proficient (3.9%), adequate (15.6%), sufficient (16.9%), or poor (63.6%). When asked about the first mU gene they thought of, 60.4% mentioned NOD2, 3.9% mentioned NLRP3 or MEFV, and 49.4% provided incorrect or no answers. Success rates in clinical scenarios va"],"journal":["Ophthalmology and therapy"],"pagination":["127-147"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10776548"],"repository":["biostudies-literature"],"pubmed_title":["Knowledge and Current Practices in Monogenic Uveitis: An International Survey by IUSG and AIDA Network."],"pmcid":["PMC10776548"],"pubmed_authors":["Carreno E","Pleyer U","Gupta V","Cantarini L","Gaggiano C","Frediani B","Tosi GM","Cunningham ET","Pavesio CE","Denisova EV","Goldstein D","de-la-Torre A","Babu K","Yang P","Sobrin L","Davis JL","Sridharan S","Fonollosa A","De Smet MD","Agrawal R","Paroli MP","Fabiani C"],"additional_accession":[]},"is_claimable":false,"name":"Knowledge and Current Practices in Monogenic Uveitis: An International Survey by IUSG and AIDA Network.","description":"<h4>Introduction</h4>This study aims to explore awareness, knowledge, and diagnostic/therapeutic practices in monogenic uveitis (mU) among uveitis experts.<h4>Methods</h4>This is an explorative, cross-sectional survey study. An anonymous, semi-structured, electronic survey was delivered to uveitis experts from the Autoinflammatory Diseases Alliance (AIDA) Network and International Uveitis Study Group (IUSG). We included respondents answering ≥ 50% of the survey.<h4>Results</h4>Seventy-seven participants rated their knowledge of mU as proficient (3.9%), adequate (15.6%), sufficient (16.9%), or poor (63.6%). When asked about the first mU gene they thought of, 60.4% mentioned NOD2, 3.9% mentioned NLRP3 or MEFV, and 49.4% provided incorrect or no answers. Success rates in clinical scenarios va","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Jan","modification":"2025-04-22T00:55:32.724Z","creation":"2025-04-05T19:46:14.31Z"},"accession":"S-EPMC10776548","cross_references":{"pubmed":["37924480"],"doi":["10.1007/s40123-023-00839-1"]}}